Quanterix President, Chairman and Chief Executive Officer Kevin Hrusovsky hosts a panel discussion discussing the role of blood-based biomarkers and highlighting insights from the AD/PD 2021 conference, along with Dr. Andreas Jeromin, Independent Medical Advisor, Dr. Mark Roskey, SVP, Quanterix, and Dr. Paula Perin, Principal Application Scientist, Quanterix.

Watch the Video